BRPI0922623A2 - comprimido farmacêutico de liberação controlada - Google Patents

comprimido farmacêutico de liberação controlada

Info

Publication number
BRPI0922623A2
BRPI0922623A2 BRPI0922623A BRPI0922623A BRPI0922623A2 BR PI0922623 A2 BRPI0922623 A2 BR PI0922623A2 BR PI0922623 A BRPI0922623 A BR PI0922623A BR PI0922623 A BRPI0922623 A BR PI0922623A BR PI0922623 A2 BRPI0922623 A2 BR PI0922623A2
Authority
BR
Brazil
Prior art keywords
controlled release
release pharmaceutical
pharmaceutical tablet
tablet
controlled
Prior art date
Application number
BRPI0922623A
Other languages
English (en)
Inventor
Dirk Pamperin
Korinde Annemarie Jansen
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42099055&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0922623(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of BRPI0922623A2 publication Critical patent/BRPI0922623A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0922623A 2008-12-24 2009-12-21 comprimido farmacêutico de liberação controlada BRPI0922623A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14071208P 2008-12-24 2008-12-24
PCT/EP2009/009206 WO2010072401A1 (en) 2008-12-24 2009-12-21 Low dose controlled release tablet

Publications (1)

Publication Number Publication Date
BRPI0922623A2 true BRPI0922623A2 (pt) 2016-09-13

Family

ID=42099055

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0922623A BRPI0922623A2 (pt) 2008-12-24 2009-12-21 comprimido farmacêutico de liberação controlada

Country Status (11)

Country Link
US (1) US8465770B2 (pt)
EP (1) EP2376066A1 (pt)
KR (1) KR20110104076A (pt)
BR (1) BRPI0922623A2 (pt)
CL (1) CL2011001554A1 (pt)
CO (1) CO6390099A2 (pt)
EA (1) EA201170880A1 (pt)
EC (1) ECSP11011188A (pt)
MX (1) MX2011006679A (pt)
WO (1) WO2010072401A1 (pt)
ZA (1) ZA201104564B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012011051A (es) * 2010-03-25 2013-01-29 Aop Orphan Pharmaceuticals Ag Composicion novedosa para el tratamiento de trombocitemia esencial.
KR20160100570A (ko) * 2015-02-16 2016-08-24 한미약품 주식회사 탐수로신 염산염 함유 서방성 과립을 포함하는 경구용 약제학적 제제
RU2018142485A (ru) * 2016-05-04 2020-06-04 Эспен Парк Фармасьютикалз, Инк. Отсроченное высвобождение тамсулозина гидрохлорида после перорального введения

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPH066565B2 (ja) 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
HU226456B1 (en) 1992-09-18 2008-12-29 Astellas Pharma Inc Sustained-release hydrogel preparation
DK0612724T3 (da) * 1993-02-23 1997-06-16 Hoechst Ag Substituerede benzensulfonylurinstoffer og -thiourinstoffer, fremgangsmåde til deres fremstilling og deres anvendelse som farmaceutika
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
US6177430B1 (en) * 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
US6835853B2 (en) * 2001-10-31 2004-12-28 Synthon Bv Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
WO2003039530A1 (en) * 2001-11-07 2003-05-15 Synthon B.V. Tamsulosin tablets
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
US7442387B2 (en) 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
KR20070044911A (ko) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 염산 탐스로신 함유 방출조절 제제
WO2007131804A1 (en) 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
KR100885029B1 (ko) * 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제

Also Published As

Publication number Publication date
US8465770B2 (en) 2013-06-18
WO2010072401A1 (en) 2010-07-01
US20100092552A1 (en) 2010-04-15
ZA201104564B (en) 2012-09-26
ECSP11011188A (es) 2011-08-31
CO6390099A2 (es) 2012-02-29
EP2376066A1 (en) 2011-10-19
CL2011001554A1 (es) 2012-04-09
MX2011006679A (es) 2011-09-28
EA201170880A1 (ru) 2012-02-28
KR20110104076A (ko) 2011-09-21

Similar Documents

Publication Publication Date Title
LTPA2020003I1 (lt) Dvisluoksnės tabletės formuluotės
BR112012011733A2 (pt) formulações de comprimido de liberação imediata
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0908114A2 (pt) tabuleta oral de liberação controlada
DK2345410T3 (da) Farmaceutisk sammensætning til modificeret frigivelse
BR112012011902A2 (pt) cápsula farmacêutica
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
SMT201400069B (it) Formulazione farmaceutica
IL207378A0 (en) Pharmaceutical solid state forms
BRPI1015939A2 (pt) composição farmacêutica
BRPI1016190A2 (pt) compostos farmacêuticos.
BRPI0906754A2 (pt) Formulário de dosage prolongado da libertação de paliperidone
GB0810615D0 (en) Novel pharmaceutical
BRPI0915427A2 (pt) composição farmacêutica
BR112012002271A2 (pt) cápsulas de liberação sustentada
BRPI0912428A2 (pt) formulação farmacêutica sólida de liberação retardada
BRPI0921654A2 (pt) formulação farmacêutica
BRPI0922653A2 (pt) preparação farmacêutica
DK2271618T3 (da) Farmaceutiske forbindelser
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
BRPI0922423A2 (pt) dispositivo de liberação de fármaco
BRPI1009367A2 (pt) tablete de camada múltipla
BR112012003149A2 (pt) composição farmacêutica
BRPI0912171A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.